Investing.com - Rubicon Research Limited, a pharmaceutical formulations company, has filed an addendum to its Draft Red Herring Prospectus (DRHP) with SEBI, updating its financial information for FY25 ...

Investing.com -- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) stock surged 23% after the FDA lifted a clinical hold on the company’s pivotal Phase 2 trial of RP-A501 for the treatment of Danon disease.

Investing.com -- China is considering permitting yuan-backed stablecoins for the first time as part of efforts to increase ...

Looking ahead, TJX raised its full-year earnings guidance to $4.52-$4.57 per share, above the analyst consensus of $4.51.

Securities (BofA) lifted its rating on Snowflake (NYSE:SNOW) to Buy from Neutral and raised its price objective (PO) to $240 ...

Hong Kong and Chinese authorities say Lai is being given a fair trial. Lai’s lawyer Robert Pang, who began his final legal ...

Rolls-Royce (LON: RR) continues to outperform after a sharp turnaround. Its civil aerospace and power systems divisions ...

SINGAPORE (Reuters) -European shares steadied on Wednesday, as a tech-led selloff on Wall Street that has rippled through equity markets eased, while currency and rates traders honed in on a key ...

“Consistent with AMD’s recently reported results, we expect NVDA’s F3Q guidance to exclude direct contributions from the China market,” KeyBanc wrote. The note also flagged “a potential 15% tax on AI ...

Investing.com -- enVVeno Medical (TASE: BLWV) Corporation (NASDAQ: NVNO) stock plummeted 70% after the company received a not-approvable letter from the U.S. Food and Drug Administration for its ...

Markets are currently indicating an 84% chance for a quarter-point rate cut at the Fed’s next policy meeting in September. Oil prices rose Wednesday, bouncing after the previous session’s losses as ...

S&P 500, Bank of America Corp, Deutsche Bank AG NA O.N., SPDR® S&P 500® ETF Trust. Read 's Market Analysis on Investing.com AU.